Chemoradiotherapy for locally advanced pancreatic carcinoma in elderly patients

Oncology

Volumn 68, Issue 4-6, 2005, Pages 432-437

  Morizane, Chigusa ^a   Okusaka, Takuji ^a   Ito, Yoshinori ^a   Ueno, Hideki ^a   Ikeda, Masafumi ^a   Takezako, Yoriko ^a   Kagami, Yoshikazu ^a   Ikeda, Hiroshi ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Chemoradiotherapy; Elderly; Pancreatic carcinoma

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; FLUOROURACIL; HEMOGLOBIN; MORPHINE; SERUM ALBUMIN;

ABDOMINAL PAIN; ADULT; AGED; ALBUMIN BLOOD LEVEL; AMINO ACID BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ANOREXIA; ARTICLE; BACKACHE; BILIRUBIN BLOOD LEVEL; BLOOD TOXICITY; CANCER GRADING; CLINICAL ARTICLE; CONSTIPATION; DIARRHEA; DRUG TOLERABILITY; FATIGUE; FEMALE; GERONTOLOGY; HEMOGLOBIN DETERMINATION; HUMAN; HYPERGLYCEMIA; INFUSION; LEUKOCYTE COUNT; MALE; NAUSEA; NEUTROPHIL; PANCREAS CARCINOMA; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; SIDE EFFECT; STOMATITIS; THROMBOCYTE COUNT; TREATMENT OUTCOME; VOMITING; WEIGHT REDUCTION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; HUMANS; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; PANCREATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 23844511851     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086985     Document Type: Article

References (31)

1. Moertel CG, Childs DS Jr, Reitemeier RJ, et al: Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 1969;ii:865-867.
2. Moertel CG, Frytak S, Hahn RG, et al: Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group. Cancer 1981;48:1705-1710.
3. Treatment of locally unresectable carcinoma of the pancreas: Comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study Group. J Natl Cancer Inst 1988;80:751-755.
4. Ishii H, Okada S, Tokuuye K, et al: Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma. Cancer 1997;79:1516-1520.
5. Okusaka T, Okada S, Tokuuye K, et al: Lack of effectiveness of radiotherapy combined with cisplatin in patients with locally advanced pancreatic carcinoma. Cancer 2001;91:1384-1389.
6. Ludbrook JJ, Truong PT, MacNeil MV, et al: Do age and comorbidity impact treatment allocation and outcomes in limited stage small-cell lung cancer? A community-based population analysis. Int J Radiat Oncol Biol Phys 2003;55:1321-1330.
7. Kim HK, Silver B, Li S, et al: Hodgkin's disease in elderly patients (> or = 60): Clinical outcome and treatment strategies. Int J Radiat Oncol Biol Phys 2003;56:556-560.
8. Begg CB, Carbone PP: Clinical trials and drug toxicity in the elderly. The experience of the Eastern Cooperative Oncology Group. Cancer 1983;52:1986-1992.
9. Arias F, Duenas M, Martinez E, et al: Radical chemoradiotherapy for elderly patients with bladder carcinoma invading muscle. Cancer 1997;80:115-120.
10. Popescu RA, Norman A, Ross PJ, et al: Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older. J Clin Oncol 1999;17:2412-2418.
11. Pignon T, Gregor A, Schaake Koning C, et al: Age has no impact on acute and late toxicity of curative thoracic radiotherapy. Radiother Oncol 1998;46:239-248.
12. Sengelov L, Klintorp S, Havsteen H, et al: Treatment outcome following radiotherapy in elderly patients with bladder cancer. Radiother Oncol 1997;44:53-58.
13. Huguenin PU, Glanzmann C, Hammer F, Lutolf UM: Endometrial carcinoma in patients aged 75 years or older: Outcome and complications after postoperative radiotherapy or radiotherapy alone. Strahlenther Onkol 1992;168:567-572.
14. Zachariah B, Balducci L: Radiation therapy of the older patient. Hematol Oncol Clin North Am 2000;14:131-167.
15. Pignon T, Horiot JC, Van den Bogaert W, et al: No age limit for radical radiotherapy in head and neck tumours. Eur J Cancer 1996;32A:2075-2081.
16. Pignon T, Horiot JC, Bolla M, et al: Age is not a limiting factor for radical radiotherapy in pelvic malignancies. Radiother Oncol 1997;42:107-120.
17. DiCarlo V, Balzano G, Zerbi A, Villa E: Pancreatic cancer resection in elderly patients. Br J Surg 1998;85:607-610.
18. Fong Y, Blumgart LH, Fortner JG, Brennan MF: Pancreatic or liver resection for malignancy is safe and effective for the elderly. Ann Surg 1995;222:426-434.
19. Hannoun L, Christophe M, Ribeiro J, et al: A report of forty-four instances of pancreaticoduodenal resection in patients more than seventy years of age. Surg Gynecol Obstet 1993;177:556-560.
20. Hodul P, Tansey J, Golts E, et al: Age is not a contraindication to pancreaticoduodenectomy. Am Surg 2001;67:270-275; discussion 275-276.
21. Kayahara M, Nagakawa T, Ueno K, et al: Pancreatic resection for periampullary carcinoma in the elderly. Surg Today 1994;24:229-233.
22. Richter A, Schwab M, Lorenz D, et al: Surgical therapy of pancreatic carcinoma in elderly patients over 70. Langenbecks Arch Chir Suppl Kongressbd 1996;113:492-494.
23. Magistrelli P, Masetti R, Coppola R, et al: Pancreatic resection for periampullary cancer in elderly patients. Hepatogastroenterology 1998;45:242-247.
24. Spencer MP, Sarr MG, Nagorney DM: Radical pancreatectomy for pancreatic cancer in the elderly. Is it safe and justified? Ann Surg 1990;212:140-143.
25. Bathe OF, Levi D, Caldera H, et al: Radical resection of periampullary tumors in the elderly: Evaluation of long-term results. World J Surg 2000;24:353-358.
26. Miller AB, Hoogstraten B, Staquet M, Winkler A: Reporting results of cancer treatment. Cancer 1981;47:207-214.
27. Ikeda M, Okada S, Tokuuye K, et al: Prognostic factors in patients with locally advanced pancreatic carcinoma receiving chemoradiotherapy. Cancer 2001;91:490-495.
28. Kelsen DP, Portenoy R, Thaler H, et al: Pain as a predictor of outcome in patients with operable pancreatic carcinoma. Surgery 1997;122:53-59.
29. Leichman CG: Prolonged infusion of fluorinated pyrimidines in gastrointestinal malignancies: A review of recent clinical trials. Cancer Invest 1994;12:166-175.
30. Poen JC, Collins HL, Niederhuber JE, et al: Chemo-radiotherapy for localized pancreatic cancer: Increased dose intensity and reduced acute toxicity with concomitant radiotherapy and protracted venous infusion 5-fluorouracil. Int J Radiat Oncol Biol Phys 1998;40:93-99.
31. Krzyzanowska MK, Weeks JC, Earle CC: Treatment of locally advanced pancreatic cancer in the real world: Population-based practices and effectiveness. J Clin Oncol 2003;21:3409-3414.